Evaluation of a novel vesicular stomatit
โ
Shuetsu Fukushi; Tetsuya Mizutani; Masayuki Saijo; Ichiro Kurane; Fumihiro Taguc
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 88 KB
Severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV) is the causative agent of SARS. The S protein of SARS-CoV is a major target for neutralizing antibodies (Nabs) in infected patients. We developed a neutralization assay using a recombinant vesicular stomatitis virus (VSV) bearing SARS-C